Results 161 to 170 of about 6,601,558 (278)

Ultrasound‐guided versus open surgical central venous access in children: A systematic review

open access: yesJournal of Parenteral and Enteral Nutrition, EarlyView.
Abstract Central venous catheters (CVCs) are essential in pediatric care for long‐term venous access. While tunneled CVCs have traditionally been placed using open surgical venotomy or cut‐down (OS), ultrasound‐guided (USG) percutaneous insertion is widely used.
Michiel F. Lagerweij   +9 more
wiley   +1 more source

Ultrasound findings associated with neonatal acute liver failure secondary to gestational alloimmune liver disease: A case series

open access: yesJPGN Reports, EarlyView.
Abstract Objectives Gestational alloimmune liver disease is the leading cause of neonatal acute liver failure, hypothesized to emerge from maternal exposure to an antigen that is expressed on fetal hepatocytes, resulting in maternal‐fetal alloimmune attack and activation of the complement cascade.
Naseem Ravanbakhsh   +6 more
wiley   +1 more source

New filamin A gene mutation identified in X‐linked pediatric intestinal pseudo‐obstruction: A case report

open access: yesJPGN Reports, EarlyView.
Abstract Pediatric intestinal pseudo‐obstruction (PIPO) represents a severe gut motility disorder leading to digestive complications with high morbidity and mortality. Neonates and young children present symptoms mimicking intestinal occlusion, leading to surgery and long‐term feeding support.
Leonor Belfond   +6 more
wiley   +1 more source

Internal mammary artery injury complicating a Surfacer inside-out central venous catheterization. [PDF]

open access: yesJ Vasc Surg Cases Innov Tech, 2023
Bohle K   +4 more
europepmc   +1 more source

Diffuse gallbladder epithelial proliferation after teduglutide exposure: A case report

open access: yesJPGN Reports, EarlyView.
Abstract Teduglutide, a glucagon‐like peptide 2 analog that increases mucosal proliferation in the gastrointestinal tract, was approved by the U.S. Food and Drug Administration for use in children with intestinal failure in 2019 after trials of 12‐ and 24‐week duration.
Christopher P. Duggan   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy